LHUB-ULB, founded in 2015, is a prominent clinical biology laboratory linked with the academic hospitals of Brussels, including Bordet, Erasme, St-Pierre, and HUDERF. It ranks among the top five university hospital laboratories in Europe, cementing its international reputation for excellence.
With its headquarters in the vibrant city of Brussels, LHUB-ULB operates a multi-site platform with a central technical hub at Porte de Hal, and proximity labs at Anderlecht, Laeken, and Schaerbeek. It performs over 19 million analyses annually, serving both hospitalized and ambulatory patients.
The laboratory’s importance lies not just in its diagnostic services but also in its consultative role, where specialized medical and pharmaceutical biologists provide expert guidance. This integrates seamlessly with their commitment to education and research, emphasizing the lab’s vital function in the healthcare and pharmaceutical industries.
No prior investments have been recorded for LHUB-ULB, presenting a unique opportunity for investors seeking to enter the thriving European healthcare market.
